TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s February 28, 1992
TCL Archive In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two December 4, 1992